{"id":"fluvestrin-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Edema"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Increased vascular permeability"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fluvestrin works by binding to VEGF receptors on endothelial cells, stimulating the formation of new blood vessels (angiogenesis) and improving vascular permeability. This mechanism aims to restore blood supply to tissues affected by ischemia, potentially improving tissue perfusion and function in conditions with inadequate blood flow.","oneSentence":"Fluvestrin is a recombinant human vascular endothelial growth factor (VEGF) that promotes angiogenesis and improves blood flow to ischemic tissues.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:46:51.831Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction"},{"name":"Chronic heart failure with reduced ejection fraction"}]},"trialDetails":[{"nctId":"NCT05375461","phase":"PHASE3","title":"TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-03-18","conditions":"HR-positive,HER2-negative in Advanced Breast Cancer","enrollment":287}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":595852,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fluvestrin injection","genericName":"Fluvestrin injection","companyName":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","companyId":"chia-tai-tianqing-pharmaceutical-group-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluvestrin is a recombinant human vascular endothelial growth factor (VEGF) that promotes angiogenesis and improves blood flow to ischemic tissues. Used for Acute myocardial infarction, Chronic heart failure with reduced ejection fraction.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}